<!DOCTYPE html>
<html lang="en-gb">
<head>
  
  <meta charset="utf-8" />
  <meta content="IE=edge,chrome=1" name="X-UA-Compatible" />
  <meta content="width=device-width, initial-scale=1, maximum-scale=1" name="viewport" />
  
  <!-- meta tags -->
  <meta content="NICE" name="DC.Publisher" />
  <meta content="All content on this site is NICE copyright unless otherwise stated. You can download material for private research, study or in-house use only. Do not distribute or publish any material from this site without first obtaining NICE's permission. Where Crown copyright applies, see the Office of Public Sector Information (formerly HMSO) website for information." name="DC.Rights.Copyright" />
  <meta content="eng" name="DC.Language" scheme="DCTERMS.ISO639-2T" />
  <meta content="Health, well-being and care" name="DC.Subject" scheme="eGMS.IPSV" />
  <meta content="Double-A" name="eGMS.accessibility" scheme="eGMS.WCAG10" />
  <meta content="2014-08-05" name="DC.Issued" scheme="DCTERMS.W3CDTF" />
  <meta content="2014-08-05" name="DC.Modified" scheme="DCTERMS.W3CDTF" />
  <meta content="CorporatePage" name="DC.Type" scheme="NICE.Publication.Types" />
  
  <meta content="BNF: British National Formulary - NICE" name="DC.Title" />
  
  <title>POTASSIUM CHLORIDE | Drug | BNF content published by NICE</title>
  <meta name="description" content="Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for POTASSIUM CHLORIDE."/>
  <meta name="author" content="NICE - The National Institute for Health and Care Excellence" />

  	<link rel="alternate" type="application/json" href="/drug/potassium-chloride.json" title="RDF/JSON version of this document"/>
  	<link rel="alternate" type="text/turtle" href="/drug/potassium-chloride.ttl" title="Turtle version of this document"/>
  <!--[if lt IE 9]>
  <script src="//cdn.nice.org.uk/V3.1/Scripts/html5shiv/html5shiv.js"></script>
  <![endif]-->
  
  <!-- Le styles -->
  <link href="//fonts.googleapis.com/css?family=Lato:300normal,300italic,400normal,400italic,700normal,700italic" rel="stylesheet"/>
  <link href="//cdn.nice.org.uk/V3.1/Content/NICE.bootstrap.css" rel="stylesheet">
  <link rel="stylesheet" href="//maxcdn.bootstrapcdn.com/font-awesome/4.5.0/css/font-awesome.min.css">
  
  <!--[if IE 7]>
  <link href="//cdn.nice.org.uk/V3.1/Content/NICE.glyphs-ie7.css" rel="stylesheet"/>
  <![endif]-->
  
  <meta content="#f6f6f6" name="msapplication-TileColor" />
  <meta content="//cdn.nice.org.uk/V3.1/Content/nice/favicon-144.png" name="msapplication-TileImage" />
  <link rel="shortcut icon" href="//cdn.nice.org.uk/V3.1/Content/nice/favicon.ico" />
  <link rel="apple-touch-icon-precomposed" href="//cdn.nice.org.uk/V3.1/Content/nice/favicon-152.png">
  
  <link href="/styles/style.css" rel="stylesheet" type="text/css" />
  <link href="/styles/bnf.css" rel="stylesheet" type="text/css" />
</head>
<body id="potassium-chloride" class="drug" data-publication="bnf" data-buildnumber="1.0.119-Live" data-release="live">
  
  
  <!-- Google Tag Manager -->
  <div id='gtmscript'></div>
  <noscript>
    <iframe src="//www.googletagmanager.com/ns.html?id=GTM-WF3WHX"
      height="0" width="0" style="display:none;visibility:hidden"></iframe>
  </noscript>
  <script>
    (function (w, d, s, l, i) {
      w[l] = w[l] || []; w[l].push({
        'gtm.start': new Date().getTime(), event: 'gtm.js'
      }); var f = d.getElementsByTagName(s)[0],
              j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
                '//www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
    })(window, document, 'script', 'dataLayer', 'GTM-WF3WHX');
  </script>
  <!-- End Google Tag Manager -->
  <div id="global-nav-header"></div>  <div class="container topic-container">
    
    <ul class="breadcrumb">
      <li><a href="../">Home</a> <span class="divider icon-nice-chevron-right"></span></li>
      <li><a href="./">Drugs</a> <span class="divider icon-nice-chevron-right"></span></li>
      <li class="active"><span>POTASSIUM CHLORIDE</span></li>
    </ul>
  </div>
  
	<div class="container sticky-notice">
			<div id="site-distinction" class="bnf">
				<p>You are viewing BNF. If you require BNF for Children, use <a href="https://bnfc.nice.org.uk">BNFC.</a></p>
			</div>	</div>

  <div class="layout search-container hidden">
    <div id="search-results">
    </div>
  </div>
  <div class="layout">
    <h1 id=""><span>POTASSIUM CHLORIDE</span></h1>
  </div>


  <div class="layout layout-secondary-wide topic-container">

    <div class="content content-primary">
      <nav class="nav-toggle">
        <ul class="index unstyled nav-subtopics">
          <li>
            <a class="btn btn-transparent">
              <i class="pull-right icon-chevron-down"></i>
              <span>Show all parts of this monograph</span>
            </a>
          </li>
        </ul>
      </nav>

      <nav class="monograph-navigation">
        <ul class="index unstyled nav-subtopics grid2">
            <li class="active"><a href="#indicationsAndDoses" class="scroll-to-href">Indications and dose</a></li>
            <li><a href="#importantSafetyInformations" class="scroll-to-href">Important safety information</a></li>
            <li><a href="#contraIndications" class="scroll-to-href">Contra-indications</a></li>
            <li><a href="#cautions" class="scroll-to-href">Cautions</a></li>
          <li><a href="#interactions" class="scroll-to-href">Interactions</a></li>
            <li><a href="#sideEffects" class="scroll-to-href">Side-effects</a></li>
            <li><a href="#renalImpairment" class="scroll-to-href">Renal impairment</a></li>
            <li><a href="#monitoringRequirements" class="scroll-to-href">Monitoring requirements</a></li>
            <li><a href="#directionsForAdministration" class="scroll-to-href">Directions for administration</a></li>
            <li><a href="#prescribingAndDispensingInformations" class="scroll-to-href">Prescribing and dispensing information</a></li>
            <li><a href="#patientAndCarerAdvice" class="scroll-to-href">Patient and carer advice</a></li>
            <li><a href="#lessSuitableForPrescribings" class="scroll-to-href">Less suitable for prescribing</a></li>
            <li><a href="#medicinalForms" class="scroll-to-href">Medicinal forms</a></li>
        </ul>
      </nav>

      <div id="monograph-content" class="">
      
        <section class="scroll-target" id="indicationsAndDoses">
          <h2>Indications and dose</h2>
      
      
          <div class="prescribingInformation">
          <section class="indicationsAndDose">
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Prevention of hypokalaemia (patients with normal diet)</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By mouth</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>2&#8211;4&#8239;g daily in divided doses.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Electrolyte imbalance</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous infusion</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>Dose dependent on deficit or the daily maintenance requirements.</p>
                  </li>
                </ul>
              </div>
            </section>
          </section>
          </div>
      
        </section>
      
      
        <section class="scroll-target" id="importantSafetyInformations">
          <h2>Important safety information</h2>
      
      
          <div class="prescribingInformation">
          <section class="importantSafetyInformation">
              <section class="advice ImportantSafetyInformation">
                <h4>Safe practice</h4>
                <div>
                              
                              <p>Potassium overdose can be fatal. Ready-mixed infusion solutions containing potassium should be used. Exceptionally, if potassium chloride concentrate is used for preparing an infusion, the infusion solution should be <strong>thoroughly mixed</strong>. Local policies on avoiding inadvertent use of potassium chloride concentrate should be followed.</p>
                            </div>
              </section>
              <section class="advice ImportantSafetyInformation">
                <h4>NHS Never Event: Mis-selection of a strong potassium solution (January 2018) </h4>
                <div>
                              
                              <p>Patients should not be inadvertently given a strong potassium solution (&#8805;10% potassium w/v ) intravenously, rather than the intended medication.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="contraIndications">
          <h2>Contra-indications</h2>
      
      
          <div class="prescribingInformation">
          <section class="generalContraIndications">
              <section class="advice ContraindicationsGroup,GeneralContraindications">
                <p>
                              <span class="contraindication">Plasma-potassium concentration above 5&#8239;mmol/litre</span>
                            </p>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="cautions">
          <h2>Cautions</h2>
      
      
          <div class="prescribingInformation">
          <section class="specificCautions">
            <section class="cautionsWithRoutes">
                <section class="advice CautionsGroup,CautionsWithRoutes">
                  <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use</span></strong></p>
                  <p>
                                    <span class="caution">seek specialist advice in very severe potassium depletion or difficult cases</span>
                                  </p>
                </section>
                <section class="advice CautionsGroup,CautionsWithRoutes">
                  <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use</span></strong></p>
                  <p>
                  <span class="caution">cardiac disease</span>; <span class="caution">elderly</span>; <span class="caution">hiatus hernia (<em>with modified-release preparations</em>)</span>; <span class="caution">history of peptic ulcer (<em>with modified-release preparations</em>)</span>; <span class="caution">intestinal stricture (<em>with modified-release preparations</em>)</span></p>
                </section>
            </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="interactions">
          <h2>Interactions</h2>
      
      
      
          <div class="interactants">
            <h4>Individual interactants:</h4>
            <ul>
              <li><a href="/interaction/potassium-chloride-2.html" class="interactant"><span> Potassium chloride </span></a></li>
            </ul>
          </div>
      
        </section>
      
        <section class="scroll-target" id="sideEffects">
          <h2>Side-effects</h2>
      
      
          <div class="prescribingInformation">
          <section class="generalSideEffects">
            <h3>General side-effects</h3>
            <div class="notKnown">
              <h4>Frequency not known</h4>
                <section class="advice SideEffectsGroup,GeneralSideEffects,SideEffectGroup">
                  <p class="sideEffects">
                                    <span class="sideEffect">Hyperkalaemia</span>
                                  </p>
                </section>
            </div>
          </section>
          <section class="specificSideEffects">
            <h3>Specific side-effects</h3>
            <section class="SideEffectsWithRoutes">
              <div class="notKnown">
                <h4>Frequency not known</h4>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use</span></strong></p>
                    <p>
                    <span class="sideEffect">abdominal cramps</span>; <span class="sideEffect">diarrhoea</span>; <span class="sideEffect">gastrointestinal disorders</span>; <span class="sideEffect">nausea</span>; <span class="sideEffect">vomiting</span></p>
                  </section>
              </div>
            </section>
          </section>
          </div>
      
        </section>
      
      
      
      
      
      
        <section class="scroll-target" id="renalImpairment">
          <h2>Renal impairment</h2>
      
      
          <div class="prescribingInformation">
          <section class="generalInformation">
              <section class="advice GeneralInformation">
                <div>
                              <p>Avoid in severe impairment.</p>
                            </div>
              </section>
          </section>
          <section class="doseAdjustment">
            <h3>Dose adjustments</h3>
              <section class="advice DoseAdjustment">
                <div>
                              <p>Smaller doses must be used in the prevention of hypokalaemia, to reduce the risk of hyperkalaemia.</p>
                            </div>
              </section>
          </section>
          
          <section class="additionalMonitoringInRenalImpairment">
            <h3>Monitoring</h3>
              <section class="advice AdditionalMonitoringInRenalImpairment">
                <div>
                              <p>Close monitoring required in renal impairment&#8212;high risk of hyperkalaemia.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
      
        <section class="scroll-target" id="monitoringRequirements">
          <h2>Monitoring requirements</h2>
      
      
          <div class="prescribingInformation">
          <section class="monitoringOfPatientParameters">
            <h3>Monitoring of patient parameters</h3>
              <section class="advice MonitoringOfPatientParameters,MonitoringRequirement">
                <div>
                              <p>Regular monitoring of plasma-potassium concentration is essential in those taking potassium supplements.</p>
                            </div>
              </section>
              <section class="advice MonitoringOfPatientParameters,MonitoringRequirement">
                <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use</span></strong></p>
                <div>
                              
                              <p>ECG monitoring should be performed in difficult cases.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
      
      
        <section class="scroll-target" id="directionsForAdministration">
          <h2>Directions for administration</h2>
      
      
          <div class="prescribingInformation">
          <section class="directionForAdministration">
              <section class="advice DirectionForAdministration">
                <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use</span></strong></p>
                <div>
                              
                              <p>Potassium salts are preferably given as a liquid (or effervescent) preparation, rather than modified-release tablets; they should be given as the chloride (the use of effervescent potassium tablets BPC 1968 should be restricted to <em>hyperchloraemic</em> states).</p>
                            </div>
              </section>
              <section class="advice DirectionForAdministration">
                <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use</span></strong></p>
                <div>
                              
                              <p>Potassium chloride concentrate must be diluted with <strong>not less</strong> than 50 times its volume of sodium chloride intravenous infusion 0.9% or other suitable diluent and <strong>mixed well</strong>.</p>
                            </div>
              </section>
              <section class="advice DirectionForAdministration">
                <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use</span></strong></p>
                <div>
                              
                              <p>Ready-mixed infusion solutions should be used where possible; alternatively, potassium chloride concentrate as ampoules containing 1.5&#8239;g (K<sup>+</sup> 20&#8239;mmol) in 10&#8239;mL, is <strong>thoroughly mixed</strong> with 500&#8239;mL of sodium chloride 0.9% intravenous infusion and given slowly over 2 to 3 hours with specialist advice and ECG monitoring in difficult cases.</p>
                              <p>For <em>peripheral intravenous infusion</em>, the concentration of potassium should not usually exceed 40&#8239;mmol/L.</p>
                              <p>Higher concentrations of potassium chloride may be given in very severe depletion, but require specialist advice.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="prescribingAndDispensingInformations">
          <h2>Prescribing and dispensing information</h2>
      
      
          <div class="prescribingInformation">
          <section class="prescribingAndDispensingInformation">
              <section class="advice PrescribingAndDispensingInformation">
                <div>
                              <p> Kay-Cee-L<sup class="tm">&#174;</sup> contains 1&#8239;mmol/mL each of K<sup>+</sup> and Cl<sup>-</sup>.</p>
                            </div>
              </section>
              <section class="advice PrescribingAndDispensingInformation">
                <h4>Potassium Tablets</h4>
                <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use</span></strong></p>
                <div>
                              
                              
                              <p> Do not confuse Effervescent Potassium Tablets BPC 1968 with effervescent potassium chloride tablets. Effervescent Potassium Tablets BPC 1968 do not contain chloride ions and their use should be restricted to hyperchloraemic states. </p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
      
        <section class="scroll-target" id="patientAndCarerAdvice">
          <h2>Patient and carer advice</h2>
      
      
          <div class="prescribingInformation">
              <section class="generalPatientAdvice">
              			<section class="advice GeneralPatientAdvice,PatientAndCarerAdvice">
              			  <div>
              			                <p>Patient or carers should be given advice on how to administer potassium chloride modified-release tablets.</p>
              			              </div>
              			</section>
              			<section class="advice GeneralPatientAdvice,PatientAndCarerAdvice">
              			  <h4>Salt substitutes</h4>
              			  <div>
              			                
              			                <p>A number of salt substitutes which contain significant amounts of potassium chloride are readily available as health food products (e.g. <em>LoSalt</em><sup class="tm">&#174;</sup> and <em>Ruthmol</em><sup class="tm">&#174;</sup>). These should not be used by patients with renal failure as potassium intoxication may result.</p>
              			              </div>
              			</section>
              </section>
          </div>
        </section>
      
      
      
        <section class="scroll-target" id="lessSuitableForPrescribings">
          <h2>Less suitable for prescribing</h2>
      
      
          <div class="prescribingInformation">
          <section class="lessSuitableForPrescribing">
              <section class="advice LessSuitableForPrescribing">
                <div>
                              <p>Modified-release tablets are less suitable for prescribing.</p>
                              <p>Modified-release preparations should be avoided unless effervescent tablets or liquid preparations inappropriate.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
      
        <section class="scroll-target" id="medicinalForms">
          <h2>Medicinal forms</h2>
      
          <section class="licensingVariationStatement">
            <p>There can be variation in the licensing of different medicines containing the same drug.</p>
          </section>
      
            <section class="availableFormsStatement">
              <p>Forms available from special-order manufacturers include: modified-release tablet, oral solution, solution for injection, infusion, solution for infusion</p>
            </section>
      
          <section class="medicinalForms">
            <p><a href="../medicinal-forms/potassium-chloride.html"><span>Modified-release tablet</span>,  <span>Oral solution</span>,  <span>Infusion</span>,  <span>Solution for infusion</span> </a></p>
          </section>
        </section>
      </div>

      
      <div class="back-to-top-container">
        <a class="btn btn-default back-to-top">
        	<span class="hidden-xs">Back to top</span>
        	<span class="icon-chevron-up" style="padding: 0px 4px;"></span>
      	</a>
      </div>    </div>

    <div class="content content-secondary">

        <section class="related-links scroll-target related-treatment-summary" id="related-treatment-summary">
          <h4>Related Treatment Summaries</h4>
          <ul class="">
            <li>
              <a href="../treatment-summary/poisoning-emergency-treatment.html" class="related-link"><span>Poisoning, emergency treatment</span></a>
            </li>
          </ul>
        </section>

        <section class="classifications scroll-target primary-classifications" id="primary-classifications">
          <div id="primary">
            <p>Other drugs classified as <a href="/drug-classification/primary/potassium-chloride.html" data-target="#primary" data-action="load" class="classification primary-classification">potassium</a></p>
          </div>
        </section>

      

    </div>
  </div>

  
  <div id="global-nav-footer"></div>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/jquery/jquery-1.10.2.min.js"></script>
  
  
   
  <!-- Bootstrap  -->
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/twitter.bootstrap.min.js"></script>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/NICE.bootstrap.min.js"></script>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/nice/NICE.EventTracking.js"></script>
  
  <script src="/scripts/remoteload.js"></script>
  <script src="/scripts/NICE.scrollspy.js"></script>
  <script src="/scripts/NICE.asyoutype.js"></script>
  <script src="/scripts/stickyfill.min.js"></script>
  <script src="/scripts/NICE.bnf.js"></script>
    <script>
  	    (function( $ ) {
  	      $(function() {
  	        var $backToTop = $( '#backToTop' );
  	        var $win = $( window );
  	        var opt = { min: 500, fadeSpeed: 100, scrollSpeed: 300 };
  	  
  	        $( document.body ).on('click', '#backToTop', function( ev ) {
  	          ev.preventDefault();
  	  
  	          $( "html, body" ).animate({ scrollTop: 0 }, opt.scrollSpeed );
  	        });
  	  
  	        $win.on('scroll', function() {
  	          $backToTop[ 'fade' + ( $win.scrollTop() >= opt.min ? 'In' : 'Out' ) ]( opt.fadeSpeed );
  	        });
  	      });
  	    })( jQuery );
  	  </script>
  	  	<script> 
  				var queryMatch = window.location.hash.match("q=([^&]+)");
  				var searchPlaceHolder = "Search BNFâ¦";
  				var global_nav_config = {
  				service: "bnf",
  				header: {
  					skipLinkId: "content-start",
  					cookie: true,
  					auth: {
  						environment: "live" == "live" ? "live" : "beta",
  						provider: "niceAccounts"
  					},
  					search: {
  						url: "/search?q=",
  						query: queryMatch ? decodeURIComponent(queryMatch[1]) : "",
  						autocomplete: "/typeahead?ajax=ajax",
  						placeholder: searchPlaceHolder,
  						onSearching: function(e) {
  								window.location.href = "#Search?q=" + encodeURIComponent(e.query);
  						}
  					},
  					onRendered: "globalNavRendered"
  				}
  	  	};
  	  </script>
  	  
  			<!--[if lt IE 9]>
  					<script src="//cdn.nice.org.uk/global-nav/global-nav.ie8.min.js"></script>
  			<![endif]-->
  			<script src="//cdn.nice.org.uk/global-nav/global-nav.min.js"></script>
  	
  	  
  
  
  
  <!-- Test for touch device -->
  <script type="text/javascript">
    $('body').addClass('ontouchstart' in document.documentElement ? 'touch-screen-device' : 'non-touch-screen-device');
  </script>
  
  <!-- TODO: What is this doing? -->
  <script type="text/javascript">
    $(document).ajaxSend(function (event, jqxhr, settings) { settings.url = settings.url + (~settings.url.indexOf("?") ? "&" : "?")+ "ajax=ajax"; });
  </script></body>
</html>
